The Web, which has spanned a number of networks in a broad vary of domains, is having a major affect on each facet of our lives. The subsequent technology of networks will make the most of all kinds of sources with vital sensing capabilities. Such networks will prolong past bodily linked computer systems to incorporate multimodal-information from organic, cognitive, semantic, and social networks. This paradigm shift will contain symbiotic networks of sensible medical units, and sensible telephones or cellular private computing and communication units. These devices-and the network-will be consistently sensing, monitoring, and decoding the setting; that is typically known as the Web of Issues (IoT).
We’re additionally witnessing appreciable curiosity within the “Omics” paradigm, which might be considered because the examine of a site in an enormous scale, at completely different ranges of abstraction, in an integrative method. The IoT revolution, mixed with the Omics revolution (genomics and socio-omics or social networks) and synthetic intelligence resurgence, may have vital implications for the way in which well being care is delivered in america. After discussing a imaginative and prescient for well being care sooner or later, we introduce the P9 well being care idea, adopted by a dialogue of a framework for sensible well being care. Then, we current a case examine and analysis instructions, adopted by examples of ongoing work on the Nationwide Institute of Requirements and Expertise (NIST).
We spotlight two different, but complementary, options for harnessing accessible neural sources for enhancing integration of synthetic limbs (ALs) by means of embodiment. ‘Arduous’ embodiment exploits neural and cognitive physique mechanisms by intently mimicking their unique organic capabilities. ‘Delicate’ embodiment exploits these identical mechanisms by recycling them to assist a distinct perform altogether.
Analysis interdisciplinarity: STEM versus non-STEM
Analysis collaboration amongst interdisciplinary groups has change into a typical pattern in latest days. Nevertheless, there’s a lack of proof in literature concerning which disciplines play dominant roles in interdisciplinary analysis settings. It’s also unclear whether or not the dominant function of disciplines differ between STEM (Science, Expertise, Engineering, and Arithmetic) and non-STEM centered analysis. This examine considers metadata of the analysis tasks funded by the Australian Analysis Council Discovery Grant Mission scheme. Making use of community analytics, this examine investigates the contribution of particular person disciplines within the efficiently funded tasks.

It’s famous that the disciplines Engineering, Organic Sciences and Expertise seem because the principal disciplines in interdisciplinary analysis having a STEM focus. In contrast, non-STEM interdisciplinary analysis is led by three disciplines-Research in Human Societies, Language, Communication and Tradition, and Historical past and Archaeology. For tasks entailing interdisciplinarity between STEM and non-STEM disciplines, the STEM self-discipline of Medical and Well being Sciences and the non-STEM disciplines of Psychology and Cognitive Science and Research in Human Societies seem because the main contributors. General, the network-based visualisation reveals that analysis interdisciplinarity is applied in a heterogeneous approach throughout STEM and non-STEM disciplines, and there are gaps in inter-disciplinary collaborations amongst some disciplines.
Chinese language natural drugs for vascular cognitive impairment in cerebral small vessel illness: A protocol for systematic evaluation and meta-analysis of randomized managed trials
cerebral small vessel illness (CSVD) is the commonest etiology of vascular cognitive impairment (VCI). VCI in CSVD (CSVD-VCI) exhibits a progressive course with a number of phases and can also be related to dysfunctions similar to gait, emotional and behavioral, and urinary disturbances, which significantly have an effect on the life high quality of aged individuals. In mainland China, Chinese language natural drugs (CHM) is clinically used for CSVD-VCI and presenting constructive efficacy, however the proof revealed in related scientific trials has not been systematically evaluated. The aim of this examine is to evaluate the present proof accessible for the scientific efficacy and security of CHM for CSVD-VCI.
A literature search of printed RCTs as much as April 30, 2020, has been performed within the following 7 digital databases: PubMed, Embase, the Cochrane Library, Chinese language Nationwide Information Infrastructure Database (CNKI), Chinese language Science and Expertise Journals Database (VIP), Wanfang Database, and Chinese language Biomedical Literature Service System (SinoMed). For unpublished research, 2 scientific trial on-line registration web sites will likely be searched: ClinicalTrials.gov and Chinese language Medical Trial Registry (ChiCTR). Solely randomized managed trials (RCTs) utilizing CHM within the therapy of sufferers with CSVD-VCI, which compares CHM with no therapy, placebo, or different standard remedies, will likely be included on this systematic evaluation.
Main outcomes will likely be set as acknowledged scales measuring cognitive perform. Secondary outcomes will contain actions of every day dwelling, behavioral, and psychological signs, world efficiency of dementia, neurological perform, organic markers of endothelial dysfunction, the scientific efficient fee, and opposed occasions. After screening research and extracting knowledge, the Cochrane Collaborations software for assessing danger of bias will likely be utilized to evaluate the methodological high quality of included RCTs. Evaluate Supervisor Model 5.three software program will likely be used for knowledge synthesis and statistical evaluation.
Purified Human Plasminogen protein biologically active |
PLMN15-N |
Alpha Diagnostics |
120 U |
EUR 562.8 |
Rat Recombinant VEGF164 (VEGF-A) Protein (E.Coli), biologically active |
VEGF33-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Rat Recombinant VEGF164 (VEGF-A) Protein (E.Coli), biologically active |
VEGF33-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2973.6 |
Mouse Recombinant VEGF164 (VEGF-A) Protein (Sf9), biologically active |
VEGF34-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Mouse Recombinant VEGF164 (VEGF-A) Protein (Sf9), biologically active |
VEGF34-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2973.6 |
Mouse Recombinant VEGF165 (VEGF-A) Protein (E.Coli), biologically active |
VEGF35-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Mouse Recombinant VEGF165 (VEGF-A) Protein (E.Coli), biologically active |
VEGF35-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2690.4 |
Purified Recombinant Human BMP3 protein, Biologically active |
BMP35-R-10 |
Alpha Diagnostics |
10 ug |
EUR 489.6 |
Purified Recombinant Human BMP4 protein, Biologically active, |
BMP45-R-10 |
Alpha Diagnostics |
10 ug |
EUR 1074 |
Purified Recombinant Human BMP4 protein, Biologically active |
BMP45-R-5 |
Alpha Diagnostics |
5 ug |
EUR 634.8 |
Purified Recombinant Human BMP6 protein, Biologically active |
BMP65-R-20 |
Alpha Diagnostics |
20 ug |
EUR 1074 |
Human Recombinant VEGF121 Protein (Sf9), biologically active |
VEGF24-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF121 Protein (Sf9), biologically active |
VEGF24-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Human Recombinant VEGF121 Protein (E.Coli), biologically active |
VEGF25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF121 Protein (E.Coli), biologically active |
VEGF25-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Human Recombinant VEGF165 Protein (E.Coli), biologically active |
VEGF26-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF165 Protein (E.Coli), biologically active |
VEGF26-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2690.4 |
Human Recombinant VEGF165 Protein (E.Coli), biologically active |
VEGF26-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 11022 |
Human Recombinant VEGF165 Protein (Sf9), biologically active |
VEGF27-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF165 Protein (HEK), biologically active |
VEGF27-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Human Recombinant VEGF165 Protein (Sf9), biologically active |
VEGF27-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 11022 |
Human Calcineurin A-subunit protein WB +Ve control |
CALNA12-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
Human Calcineurin A-subunit Control/blocking peptide |
CALNA12-P |
Alpha Diagnostics |
100 ug |
EUR 196.8 |
Monoclonal Anti-Human Calcineurin A-subunit ascites |
CALNA13-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Purified (E.Coli) Recombinant Human BMP6 protein, Biologically active |
BMP65-R-10 |
Alpha Diagnostics |
10 ug |
EUR 634.8 |
Human Recombinant (E.Coli) Purified Noggin protein, biologically active |
NOGN15-R-20 |
Alpha Diagnostics |
20 ug |
EUR 562.8 |
Human Pancreatic Lipase (partially pure) biologically active |
PLIP15-N |
Alpha Diagnostics |
10 U |
EUR 343.2 |
Calcineurin A |
MO15055 |
Neuromics |
100 ug |
EUR 459.6 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically active |
ENST13-R-100 |
Alpha Diagnostics |
100 ug |
EUR 562.8 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically active |
ENST13-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 1951.2 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically active |
ENST13-R-250 |
Alpha Diagnostics |
250 ug |
EUR 854.4 |
Recombinant (E. coli) purified Human Angiogenin protein, biologically active |
ANGN15-R-50 |
Alpha Diagnostics |
50 ug |
EUR 927.6 |
Purified (CHO cells) Recombinant Human BMP7 protein, Biologically active |
BMP75-R-10 |
Alpha Diagnostics |
10 ug |
EUR 1074 |
Mouse Recombinant Purified Noggin-Fc protein, biologically active |
NOGN25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Mouse Recombinant Purified Noggin-Fc protein, biologically active |
NOGN25-R-25 |
Alpha Diagnostics |
25 ug |
EUR 781.2 |
Rabbit Anti-bovine Calcineurin (A+B subunits) protein, IgG, aff pure |
CALN11-A |
Alpha Diagnostics |
100 ug |
EUR 578.4 |
MBD1 Polyclonal Antibody |
A-1006 |
EpiGentek |
-
EUR 740.34
-
EUR 117.70
-
EUR 306.90
-
EUR 462.00
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
5-Methylcytosine (5-mC) Monoclonal Antibody [33D3] |
A-1014 |
EpiGentek |
-
EUR 721.20
-
EUR 82.50
-
EUR 239.80
-
EUR 456.50
|
- 100 µg
- 10 ug
- 50 ug
- 100 ug
|
5-Hydroxymethylcytosine (5-hmC) Monoclonal Antibody [HMC/4D9] |
A-1018 |
EpiGentek |
-
EUR 702.06
-
EUR 82.50
-
EUR 239.80
-
EUR 443.30
|
- 100 µg
- 10 ug
- 50 ug
- 100 ug
|
PRDM4 Polyclonal Antibody |
A-2004 |
EpiGentek |
-
EUR 754.26
-
EUR 117.70
-
EUR 284.90
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
PRDM5 Polyclonal Antibody |
A-2005 |
EpiGentek |
-
EUR 754.26
-
EUR 117.70
-
EUR 284.90
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
PRDM10 Polyclonal Antibody |
A-2010 |
EpiGentek |
-
EUR 754.26
-
EUR 117.70
-
EUR 284.90
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
PRDM11 Polyclonal Antibody |
A-2011 |
EpiGentek |
-
EUR 754.26
-
Ask for price
-
Ask for price
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
PRDM13 Polyclonal Antibody |
A-2013 |
EpiGentek |
-
EUR 754.26
-
Ask for price
-
Ask for price
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
PRDM16 Polyclonal Antibody |
A-2016 |
EpiGentek |
-
EUR 754.26
-
EUR 117.70
-
EUR 284.90
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
PRDM17 Polyclonal Antibody |
A-2017 |
EpiGentek |
-
EUR 754.26
-
EUR 117.70
-
EUR 284.90
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
EZH1 Polyclonal Antibody |
A-2018 |
EpiGentek |
-
EUR 754.26
-
EUR 117.70
-
EUR 284.90
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
HSF1 Polyclonal Antibody |
A-2401 |
EpiGentek |
-
EUR 905.64
-
EUR 235.40
-
EUR 423.50
-
EUR 574.20
|
- 200 µl
- 50 ul
- 100 ul
- 200 ul
|
PRMT3 Polyclonal Antibody |
A-3003 |
EpiGentek |
-
EUR 740.34
-
Ask for price
-
Ask for price
-
EUR 462.00
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
SET1 Polyclonal Antibody |
A-3011 |
EpiGentek |
-
EUR 754.26
-
EUR 117.70
-
EUR 284.90
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
SET07 Polyclonal Antibody |
A-3013 |
EpiGentek |
-
EUR 754.26
-
Ask for price
-
Ask for price
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
LSD1 Polyclonal Antibody |
A-3018 |
EpiGentek |
-
EUR 754.26
-
EUR 117.70
-
EUR 284.90
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
HDAC10 Polyclonal Antibody |
A-4010 |
EpiGentek |
-
EUR 754.26
-
Ask for price
-
Ask for price
-
EUR 470.80
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
PCAF Polyclonal Antibody |
A-4012 |
EpiGentek |
-
EUR 740.34
-
EUR 117.70
-
EUR 306.90
-
EUR 462.00
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Histone H3K9ac (Acetyl H3K9) Polyclonal Antibody |
A-4022 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K14ac (Acetyl H3K14) Polyclonal Antibody |
A-4023 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K18ac (Acetyl H3K18) Polyclonal Antibody |
A-4024 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K23ac (Acetyl H3K23) Polyclonal Antibody |
A-4025 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 383.90
|
|
Histone H3K56ac (Acetyl H3K56) Polyclonal Antibody |
A-4026 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K4me1 (H3K4 Monomethyl) Polyclonal Antibody |
A-4031 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K4me2 (H3K4 Dimethyl) Polyclonal Antibody |
A-4032 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 383.90
|
|
Histone H3K4me3 (H3K4 Trimethyl) Polyclonal Antibody |
A-4033 |
EpiGentek |
-
EUR 555.90
-
EUR 177.10
-
EUR 342.10
-
EUR 479.60
|
|
Histone H3K9me1 (H3K9 Monomethyl) Polyclonal Antibody |
A-4034 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K9me2 (H3K9 Dimethyl) Polyclonal Antibody |
A-4035 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K9me3 (H3K9 Trimethyl) Polyclonal Antibody |
A-4036 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K27me1 (H3K27 Monomethyl) Polyclonal Antibody |
A-4037 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K27me2 (H3K27 Dimethyl) Polyclonal Antibody |
A-4038 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K27me3 (H3K27 Trimethyl) Polyclonal Antibody |
A-4039 |
EpiGentek |
-
EUR 555.90
-
EUR 177.10
-
EUR 342.10
-
EUR 479.60
|
|
Histone H3K36me1 (H3K36 Monomethyl) Polyclonal Antibody |
A-4040 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K36me2 (H3K36 Dimethyl) Polyclonal Antibody |
A-4041 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K36me3 (H3K36 Trimethyl) Polyclonal Antibody |
A-4042 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K79me1 (H3K79 Monomethyl) Polyclonal Antibody |
A-4043 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K79me2 (H3K79 Dimethyl) Polyclonal Antibody |
A-4044 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H3K79me3 (H3K79 Trimethyl) Polyclonal Antibody |
A-4045 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H4K20me1 (H4K20 Monomethyl) Polyclonal Antibody |
A-4046 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H4K20me2 (H4K20 Dimethyl) Polyclonal Antibody |
A-4047 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 336.60
-
EUR 470.80
|
|
Histone H4K20me3 (H4K20 Trimethyl) Polyclonal Antibody |
A-4048 |
EpiGentek |
-
EUR 555.90
-
EUR 173.80
-
EUR 302.50
-
EUR 470.80
|
|
Histone H3K27ac (Acetyl H3K27) Polyclonal Antibody |
A-4708 |
EpiGentek |
-
EUR 813.42
-
EUR 173.80
-
EUR 299.20
-
EUR 510.40
|
- 100 µl
- 25 ul
- 50 ul
- 100 ul
|
CRISPR Cas9 Monoclonal Antibody [7A9] |
A-9000 |
EpiGentek |
-
EUR 573.30
-
EUR 71.50
-
EUR 200.20
-
EUR 355.30
|
- 100 µg
- 10 ug
- 50 ug
- 100 ug
|
CRISPR/Cas9 (SaCas9) Monoclonal Antibody [6H4] |
A-9001 |
EpiGentek |
-
EUR 559.38
-
EUR 70.40
-
EUR 192.50
-
EUR 338.80
|
- 100 µg
- 10 ug
- 50 ug
- 100 ug
|
CLIMP-63 Polyclonal Antibody |
A-0701 |
EpiGentek |
-
EUR 754.26
-
EUR 290.40
-
EUR 470.80
|
|
DNMT3A Polyclonal Antibody |
A-1003 |
EpiGentek |
-
EUR 740.34
-
EUR 235.40
-
EUR 462.00
|
|
DNMT3B Polyclonal Antibody |
A-1004 |
EpiGentek |
-
EUR 740.34
-
EUR 235.40
-
EUR 462.00
|
|
DNMT3L Polyclonal Antibody |
A-1005 |
EpiGentek |
-
EUR 740.34
-
EUR 235.40
-
EUR 462.00
|
|
MBD3 Polyclonal Antibody |
A-1008 |
EpiGentek |
-
EUR 740.34
-
EUR 235.40
-
EUR 462.00
|
|
MGMT Polyclonal Antibody |
A-1010 |
EpiGentek |
-
EUR 740.34
-
EUR 235.40
-
EUR 462.00
|
|
MeCP2 Polyclonal Antibody |
A-1012 |
EpiGentek |
-
EUR 740.34
-
EUR 235.40
-
EUR 462.00
|
|
TET1 Polyclonal Antibody |
A-1020 |
EpiGentek |
-
EUR 628.98
-
EUR 221.10
-
EUR 386.10
|
|
DNMT1 Polyclonal Antibody |
A-1700 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
TET2 Polyclonal Antibody |
A-1701 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
MBD2 Polyclonal Antibody |
A-1713 |
EpiGentek |
-
EUR 736.86
-
EUR 281.60
-
EUR 459.80
|
|
PRDM2 Polyclonal Antibody |
A-2002 |
EpiGentek |
-
Ask for price
-
EUR 117.70
-
EUR 284.90
|
|
PRDM3 Polyclonal Antibody |
A-2003 |
EpiGentek |
-
EUR 754.26
-
EUR 284.90
-
EUR 470.80
|
|
PRDM6 Polyclonal Antibody |
A-2006 |
EpiGentek |
-
EUR 754.26
-
EUR 284.90
-
EUR 470.80
|
|
PRDM12 Polyclonal Antibody |
A-2012 |
EpiGentek |
-
EUR 754.26
-
EUR 284.90
-
EUR 383.90
|
|
PRDM14 Polyclonal Antibody |
A-2014 |
EpiGentek |
-
EUR 754.26
-
EUR 284.90
-
EUR 470.80
|
|
EZH2 Polyclonal Antibody |
A-2019 |
EpiGentek |
-
EUR 754.26
-
EUR 284.90
-
EUR 470.80
|
|
EED Polyclonal Antibody |
A-2020 |
EpiGentek |
-
EUR 740.34
-
EUR 235.40
-
EUR 462.00
|
|
Swi2/SNF2 Polyclonal Antibody |
A-2023 |
EpiGentek |
-
EUR 742.08
-
EUR 303.60
-
EUR 463.10
|
|
SNFa/BRM Polyclonal Antibody |
A-2025 |
EpiGentek |
-
EUR 740.34
-
EUR 235.40
-
EUR 383.90
|
|
Ini1 Polyclonal Antibody |
A-2026 |
EpiGentek |
-
EUR 740.34
-
EUR 235.40
-
EUR 383.90
|
|
RNA Polymerase II Monoclonal Antibody [CTD4H8] |
A-2032 |
EpiGentek |
-
EUR 754.26
-
EUR 284.90
-
EUR 470.80
|
|
CBX5 Polyclonal Antibody |
A-2701 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
EGLN1 Polyclonal Antibody |
A-2702 |
EpiGentek |
-
EUR 580.26
-
Ask for price
-
Ask for price
|
|
RBBP4 Polyclonal Antibody |
A-2703 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
SIN3A Polyclonal Antibody |
A-2704 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
CTBP1 Polyclonal Antibody |
A-2705 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
PADI4 Polyclonal Antibody |
A-2706 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
SMARCA5 Polyclonal Antibody |
A-2707 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
IDH1 Polyclonal Antibody |
A-2708 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
CHD4 Polyclonal Antibody |
A-2709 |
EpiGentek |
-
EUR 535.02
-
EUR 322.30
-
EUR 423.50
|
|
CHAF1A Polyclonal Antibody |
A-2710 |
EpiGentek |
-
EUR 535.02
-
EUR 322.30
-
EUR 423.50
|
|
BRD7 Polyclonal Antibody |
A-2712 |
EpiGentek |
-
EUR 535.02
-
EUR 328.90
-
EUR 432.30
|
|
UHRF1 Polyclonal Antibody |
A-2714 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
UHRF2 Polyclonal Antibody |
A-2715 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
SMARCE1 Polyclonal Antibody |
A-2716 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
ACTL6A Polyclonal Antibody |
A-2717 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
MPG Polyclonal Antibody |
A-2718 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
HIF1AN Polyclonal Antibody |
A-2719 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
RNF2 Polyclonal Antibody |
A-2720 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
PCGF6 Polyclonal Antibody |
A-2721 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
SMARCB1 Polyclonal Antibody |
A-2722 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
ALKBH3 Polyclonal Antibody |
A-2723 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
BBOX1 Polyclonal Antibody |
A-2724 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
BTAF1 Polyclonal Antibody |
A-2725 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
CXXC1 Polyclonal Antibody |
A-2726 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
KDM4B Polyclonal Antibody |
A-2727 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
HELLS Polyclonal Antibody |
A-2728 |
EpiGentek |
-
EUR 742.08
-
EUR 303.60
-
EUR 463.10
|
|
ING3 Polyclonal Antibody |
A-2729 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
ING4 Polyclonal Antibody |
A-2730 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
PHC1 Polyclonal Antibody |
A-2731 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
SMARCAD1 Polyclonal Antibody |
A-2732 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
USP16 Polyclonal Antibody |
A-2733 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
SMARCC1 Polyclonal Antibody |
A-2734 |
EpiGentek |
-
EUR 742.08
-
EUR 303.60
-
EUR 463.10
|
|
ERCC6L Polyclonal Antibody |
A-2735 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
SMYD5 Polyclonal Antibody |
A-2736 |
EpiGentek |
-
EUR 580.26
-
EUR 223.30
-
EUR 353.10
|
|
Subgroup analyses, sensitivity analyses, and meta-regression will likely be performed to detect potential sources of heterogeneity. The funnel plot and Eggers take a look at will likely be developed to judge publication bias, if accessible. We’ll carry out the Grading of Suggestions Evaluation, Improvement and Analysis (GRADE) system to appraise the standard of proof.